Results 151 to 160 of about 19,211 (198)

Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma. [PDF]

Med Sci (Basel)
Jung HS, Baek GO, Yoon MG, Jang SH, Cheong JY, Kim SS, Eun JW.   +6 more
europepmc   +1 more source

An Overview of Endometriosis and Potential Pharmacogenetic Targets. [PDF]

Pharm Res
Pérez-Gómez N, Martínez-Zamora MÁ, Carmona F, Novalbos J, Abad-Santos F, Koller D, Saiz-Rodríguez M.   +6 more
europepmc   +1 more source

Associations between antihypertensive drug-related gene polymorphisms and cardiovascular outcomes in hypertensive patients: a gene-drug interaction study. [PDF]

Sci Rep
Li Z, Liu H, Chen M, Deng J, Ma Z, Huang G, Li C, Su M, Zhong H.   +8 more
europepmc   +1 more source

<i>CYP2C9</i> polymorphism is associated with susceptibility to ischemic stroke in a Chinese population. [PDF]

Ann Med
Zhang J, Jia H, Liu Y, Zhang Y, Nie H, Bao Q.   +5 more
europepmc   +1 more source

Correction to "Genotype-Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers". [PDF]

Clin Transl Sci
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62

Chemico-Biological Interactions, 2020
Warfarin is the most commonly used anticoagulant in the clinical treatment of thromboembolic diseases. The dose of warfarin varies significantly within populations, and the dose is closely related to the genetic polymorphisms of the CYP2C9 and VKORC1 genes.
Hao, Chen, Da-Peng, Dai, Shan, Zhou, Jian, Liu, Shuang-Hu, Wang, Hua-Lan, Wu, Quan, Zhou, Pei-Wu, Geng, Jia, Chong, You, Lü, Jian-Ping, Cai, Jie-Fu, Yang   +11 more
openaire   +2 more sources

ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS

Drug Metabolism and Disposition, 2005
CYP2C9 is an important member of the cytochrome P450 enzyme superfamily with some 12 CYP2C9 alleles (*1-*12) being previously reported. Recently, we identified a new CYP2C9 allele with a Leu90Pro mutation in a Chinese poor metabolizer of lornoxicam [Si D, Guo Y, Zhang Y, Yang L, Zhou H, and Zhong D (2004) Pharmacogenetics 14:465-469].
Yingjie, Guo, Yifan, Zhang, Ying, Wang, Xiaoyan, Chen, Dayong, Si, Dafang, Zhong, J Paul, Fawcett, Hui, Zhou   +7 more
openaire   +2 more sources